Download presentation
Presentation is loading. Please wait.
Published byPearl Payne Modified over 9 years ago
3
Is HIV and AIDS the same thing?
4
HIV “Human Immunodeficiency Syndrome” A specific type of virus (a retrovirus) HIV invades the helper T cells to replicate itself.
5
AIDS Acquired Immunodeficiency Syndrome HIV is the virus that causes AIDS Disease limits the body’s ability to fight infection A person with AIDS has a very weak immune system
6
Four Stages of HIV
7
Stage 1 - Primary Short, flu-like illness - occurs one to six weeks after infection no symptoms at all Infected person can infect other people
8
Stage 2 - Asymptomatic Lasts for an average of ten years This stage is free from symptoms There may be swollen glands The level of HIV in the blood drops to very low levels HIV antibodies are detectable in the blood
9
Stage 3 - Symptomatic The symptoms are mild The immune system deteriorates emergence of opportunistic infections and cancers
10
Stage 4 - HIV AIDS The immune system weakens The illnesses become more severe leading to an AIDS diagnosis
11
Opportunistic Infections associated with AIDS Bacterial Tuberculosis (TB) Strep pneumonia Viral Kaposi Sarcoma Herpes Influenza (flu)
12
Opportunistic Infections associated with AIDS Parasitic Pneumocystis carinii Fungal Candida Cryptococcus
13
Modes of HIV/AIDS Transmission
14
Through Bodily Fluids Blood products Semen Vaginal fluids Breast Milk
15
Through IV Drug Use Sharing Needles Without sterilization Increases the chances of contracting HIV
16
Through Sex
17
Mother-to-Baby Before Birth During Birth Postpartum After the birth
18
Treatment Options
19
Antiretroviral Drugs Nucleoside Reverse Transcriptase inhibitors Zidovudine, Didanosine, Emtricitabine Non-Nucleoside Transcriptase inhibitors Nevirapine, Etravirine Protease inhibitors Ritonavir, Atazanvir Entry /fusion inibitors:Maraviroc,Enfuveride vertide
20
1 st effective therapy for HIV was the nucleoside reverse transcriptase inhibitor zidovudine but this drugs or even in combination of drugs from same group were unable to suppress virus for long periods of time and patient eventually dies Later on the development of other drugs drug from other anti HIV class were also combined such as protease inhibitors indinavir. This concept of three drug therapy was quickly adapted in to clinical practice this rapidly showed impressive benefit with 60-80% decline in rates of AIDS, death and hospitalization this is called HAART (highly active antiretroviral therapy.
21
HIV Life Cycle Step 1: Fusion Step 2: Transcription reverse transcriptase Step 3: Integration Step 4: Cleavage Step 5: Packaging and Budding HIV
22
Targets for treatment of HIV (anti-retroviral drugs
23
Nucleoside Reverse Transcriptase Inhibitors Zidovudine, Emtricitabine, Didanosine Are nucleoside & nucleotide analogues
24
Mechanism of action Selective reverse transcriptase inhibitors Acts as competitive substrate inhibitors Can also be incorporated into growing viral DNA chain and causes its termination
25
Zidovudine Pharmacokinetics Orally effective Penetrates CSF Excreted through kidney
26
Side effects Bone marrow depression (leukopenia) Headache Nausea, anorexia Myopathy, fatigue
27
Continue Can be used in children in low doses, during pregnancy & delivery
28
Emtricitabine Oral formulation should not be used in a pregnant AIDs patient because it contains a propylene glycol which is a potentially toxic compound for the fetus.
29
Continue Highly absorbed orally, not affected by food. Common adverse effects GIT upset Hyperpigmentation of palms& soles
30
Didanosine Oral bioavailability is reduced by food Eliminated by the kidney Causes acute pancreatitis as a side effect & retinal damage & Peripheral neuropathy
31
Therapeutic effects for all Increase T cells partially restoring immune system Reverses AIDS dementia
32
Non-Nucleoside Transcriptase Inhibitors Nevirapine ( 1 st generstion), Etravirine ( 2 nd generation )
33
Mechanism of action Bind near the active site of the viral reverse transcriptase to inhibit its activity ( Act as a non-competitive inhibitors of reverse transcriptase enzyme )
34
Pharmacokinetics Orally effective Metabolized in liver Excretion through kidney Inducer of hepatic cytochrome P450
35
Continue Very effective for prevention of transmission of infection as a single dose at time of labor and continue as an oral doses for 3 days for the neonates
36
Side Effects Hepatotoxicity Skin reaction up to life threating as Steven-Johnson Syndrome ( mainly with nevirapine) Diarrhea Headache
37
Protease Inhibitors Protease inhibitors Ritonavir, Atazanvir
38
Mechanism of action Block the viral protease enzyme necessary to produce mature virions ( prevent polyprotein cleavage,which is necessary for the maturation of viral cells )
39
Pharmacokinetics Atazanavir oral absorption requires an acid environment Excretion via biliary elimination Enzyme inhibitors P450
40
Pharmacokinetics Ritonavir Should be taken with meals ( its oral bioavailability increases with food ) Clearance is mainly via the liver Enzyme inhibitors P450
41
Side effects for protease inhibitors Increased bleeding in hemophilic patients Increased blood sugar level ( worsening of diabetes) Changes in body fat distribution central obesity, buffalo hump, (gynecomastia)
42
Dorsocervical fat pad (“buffalo hump’)
43
Entry Inhibitors Maraviroc Mechanism of action Blocks certain strains of HIV from binding to chemokine receptor type 5 ( CCR5) thus preventing the virus from entering target cells.
44
Continue If the patient,s virus is chemokine receptor type 4, the drug will not be effective. Cross CSF Excreted mostly through feces Well tolerated & few side effects
45
Thank You!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.